Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201498PMC
http://dx.doi.org/10.1186/s13063-023-07364-3DOI Listing

Publication Analysis

Top Keywords

correction favipiravir
4
favipiravir and/or
4
and/or nitazoxanide
4
nitazoxanide randomized
4
randomized double-blind
4
double-blind placebo-controlled
4
placebo-controlled trial
4
trial early
4
early therapy
4
therapy covid-19
4

Similar Publications

Context: Recently, a few antiviral drugs viz Molnupiravir (EIDD-1931), Favipiravir, Ribavirin, Sofosbuvir, Galidesivir, and Remdesivir are shown to be beneficial against COVID-19 disease. These drugs bind to the viral RNA single strand to inhibit the virus genome replication. Similarly, recently, some artificial nucleotides, such as P, J, B, X, Z, V, S, and K were proposed to behave as potent antiviral candidates.

View Article and Find Full Text PDF

In this study, for the first time, boron oxide nanoflake is analyzed as drug carrier for favipiravir using computational studies. The thermodynamic stability of the boron oxide and favipiravir justifies the strong interaction between both species. Four orientations are investigated for the interaction between the favipiravir and the BO nanoflake.

View Article and Find Full Text PDF

Unlabelled: Favipiravir (FAV) (6-fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide) is one of the most effective antiviral drugs which is cited for action against RNA-viral infections of COVID-19. In this study, density functional theory (DFT) calculations were used to investigate three nanotubes (NTs) with FAV drug as delivery systems. The encapsulated systems (ESs) consist of FAV drug inside carbon-carbon, aluminum nitride, and boron nitride.

View Article and Find Full Text PDF

Evaluation of [F]Favipiravir in Rodents and Nonhuman Primates (NHP) with Positron Emission Tomography.

Pharmaceuticals (Basel)

March 2023

Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Rd, Atlanta, GA 30322, USA.

The COVID-19 pandemic has posed a significant challenge to global public health. In response, the search for specific antiviral drugs that can effectively treat the disease caused by the SARS-CoV-2 virus has become a priority. While significant progress has been made in this regard, much work remains to address this ongoing crisis effectively.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!